A ATHERSYS INC.
Dead · Cancelled DEAD/REGISTRATION/Cancelled/Invalidated
What this record means
The record shows that “A ATHERSYS INC.” is a cancelled Principal Register mark owned by ABT Holding Company, with the cancellation entered on May 30 2025 because the registrant failed to file a required Section 8 declaration; there is no later maintenance event. The registration covered stem‑cell related goods and services – specifically stem cells for research (Class 001), stem cells for medical, clinical and pharmaceutical use (Class 005), scientific research of stem cells (Class 042), and cell‑culture services for medical purposes (Class 044) – so a similar name used in those scientific, medical or pharmaceutical contexts would create the closest record‑based concern. The record does not give the owner control over every possible use of the wording, especially outside the listed classes. The prosecution history shows the mark moved through normal examination, received a Notice of Allowance, was allowed on the Principal Register, and later was cancelled for non‑filing; no oppositions, cancellations by third parties, or court actions appear in the supplied history. I'd treat this as a meaningful concern if you plan a name in the stem‑cell or related biotech field, but the risk is far lower for unrelated goods or services.
Informational only - not legal advice.Mark Trademark, Service Mark
| Drawing type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S) /NUMBER(S) |
| Filing basis | Use in Commerce (§1(a)). |
| Status | Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page. |
Key dates
| Application filed | May 24, 2017 |
| Published for opposition | May 29, 2018 |
| Notice of Allowance | Jul 24, 2018 |
| Registered (Principal) | Nov 20, 2018 |
| Status date | May 30, 2025 |
Goods & services
Stem cells for research or scientific purposes (not medical or clinical research)
Stem cells for medical or clinical use; stem cells for pharmaceutical purposes; pharmaceutical compositions comprising stem cells for the treatment of neurological, cardiovascular, orthopedic, inflammatory and immune diseases, disorders, conditions and injuries, solid organ transplantation and wound healing
Scientific, medical and clinical research of stem cells for medical or clinical use
Growth and expansion of stem cells in cell culture for others for medical purposes/diagnostic or treatment purposes
Owner & representation
| Owner | ABT Holding Company |
| Address | 3201 Carnegie Avenue, Cleveland, OHIO UNITED STATES 44115 |
| Entity | CORPORATION - organized in DELAWARE |
| Attorney of record | Rita E. Kline |
| Correspondent | Rita E. Kline |
| Attorney email | r********@*****.com |
| Correspondent email | 3 emails |
| Correspondent phone | 2********3 |
| Correspondent address | Cleveland, OHIO |